CBS1117
CBS1117 is a virus entry inhibitor with an IC50 of 70 nM for influenza A virus, A/Puerto Rico/8/34 (H1N1) . CBS1117 interferes with the hemagglutinin (HA) -mediated fusion process[1].
Product Specifications
CAS Number
[959245-08-0]
UNSPSC
12352005
Target
Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cbs1117.html
Purity
99.76
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CC(C)N1CCC(NC(C2=C(Cl)C=CC=C2Cl)=O)CC1
Molecular Formula
C15H20Cl2N2O
Molecular Weight
315.24
References & Citations
[1]Hussein AFA, et al. Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus. Antiviral Res. 2020 May;177:104782.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1327115-01 0.05 mg (E-Coli)
Recombinant Kluyveromyces lactis Cap-associated protein CAF20 (CAF20)
Ask
View Details MBS1327115-02 0.05 mg (Yeast)
Recombinant Kluyveromyces lactis Cap-associated protein CAF20 (CAF20)
Ask
View Details MBS1327115-03 0.2 mg (E-Coli)
Recombinant Kluyveromyces lactis Cap-associated protein CAF20 (CAF20)
Ask
View Details 
MBS1327115-04 0.5 mg (E-Coli)
Recombinant Kluyveromyces lactis Cap-associated protein CAF20 (CAF20)
Ask
View Details